Clinical Trial Update: Disclosing Dementia Risk Based on Plasma Phosphorylated Tau [NA]

View source ↗

Summary

A completed clinical trial evaluating whether plasma phosphorylated tau can disclose dementia risk in individuals with Alzheimer's disease or Mild Cognitive Imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Alzheimer Disease, Mild Cognitive Impairment | NA | Status: COMPLETED